secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aligos Therapeutics, Inc. (ALGS)
CIK:        0001799448
Form:       8-K
Filed at:   2022-06-27T23:59:59+00:00
Accession:  0001193125-22-182802
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Aligos Therapeutics reports annual meeting vote results; directors elected, auditor ratified
--------------------------------------------------------------------------------

- Elected Class II directors: Thomas Woiwode (21.3M for, 4.2M withheld), Leonid Beigelman (21.5M for, 4.0M withheld), K. Peter Hirth (21.9M for, 3.6M withheld).
- Ratification of Ernst & Young as auditor for FY2022 passed with 29.5M for, 90k against, 125 abstentions.
- Broker non-votes of ~4.0M shares on director election.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799448/000119312522182802/0001193125-22-182802-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799448/000119312522182802/d356477d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-182802

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer